FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE SURVEY FINDS CANCER PATIENTS SUPPORT COVID-19 VACCINE & MASK MANDATE
August 23, 2021 12:13 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla, Aug. 23, 2021 (GLOBE NEWSWIRE) -- A survey of more than 6,800 cancer patients conducted this month by Florida Cancer Specialists & Research Institute (FCS) found that patients...
HCW Biologics’ Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein (TOBI™) Discovery Platform
August 17, 2021 07:32 ET
|
HCW Biologics, Inc
TOBI™ Discovery Platform Creates GMP-Scale Heteromeric Fusion Protein Complexes (HFPCs) That Solve Issues with Multi-Signal Receptor Engagement on Immune Cells MIRAMAR, Fla., Aug. 17, 2021 (GLOBE...
Florida Cancer Specialists & Research Institute to mandate COVID-19 vaccines for its workforce
August 03, 2021 15:35 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla, Aug. 03, 2021 (GLOBE NEWSWIRE) -- In response to growing concerns amidst the statewide surge of COVID-19 variants, Florida Cancer Specialists & Research Institute (FCS) will...
HiberCell Appoints Mark J. Mulvihill, Ph.D., Chief Scientific Officer
June 29, 2021 08:00 ET
|
HiberCell
NEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, today announced the appointment of Mark J....
HiberCell Initiates Phase 1a Clinical Trial of HC-5404-FU, an ER Stress Modulator
June 10, 2021 08:00 ET
|
HiberCell
NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company dedicated to overcoming foundational barriers that prevent patients from living longer, cancer-free lives, today...
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
May 19, 2021 08:00 ET
|
HiberCell
Proceeds to advance pipeline of clinical product candidates focused on preventing cancer relapse and metastasis NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company...
Thesecondopinion to Host Dr. Robert M. Sapolsky, Acclaimed Best-Selling Author, Stress Expert, Biologist and Neuroscientist
February 19, 2020 09:00 ET
|
Thesecondopinion
SAN FRANCISCO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Thesecondopinion, a nonprofit offering free multidisciplinary, comprehensive second opinions to adults diagnosed with new or recurrent cancers,...
DRGT USA Announces Appointment of Dr. Elizabeth Manning Duus, as Executive Director of Clinical Development
February 05, 2019 03:22 ET
|
Druggability Technologies Holdings Ltd
NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Druggability Technologies USA today announced the expansion of the clinical team, with the addition of Dr. Elizabeth Manning Duus, who has been named...
Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors
April 16, 2018 09:00 ET
|
Biothera Pharmaceuticals, Inc.
EAGAN, Minn., April 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced the presentation of new translational data from ongoing phase 2 clinical trials combining Biothera’s...